Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Emerging infectious diseases: A proactive approach.

David E Bloom1, Steven Black2, Rino Rappuoli3

  • 1Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA 02115.

Proceedings of the National Academy of Sciences of the United States of America
|April 12, 2017
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk and protective factors for cognitive decline in older adults from a nationally representative sample in India: Results from the LASI-DAD.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Health and economic burdens of emerging infectious diseases in the USA, US territories and globally.

BMJ global health·2026
Same author

Vision loss, disability and multimorbidity among older people in Andhra Pradesh and Telangana in South India: the longitudinal eye health, ageing and disability study (LEADS) - study protocol.

BMJ public health·2026
Same author

Health Service Leaders' Perspectives on Type 1 Diabetes Models of Care for Children and Young Adults in Australia: A Mixed-Methods Study.

Journal of diabetes research·2026
Same author

Estimating the economic burden of lower respiratory infections in China from 2020 to 2040: a health-augmented macroeconomic modelling study.

The Lancet regional health. Western Pacific·2026
Same author

The full value of mRNA seasonal influenza and endemic-stage COVID-19 combination vaccines: a taxonomy.

Journal of medical economics·2026
Same journal

Costunolide ameliorates autoimmune uveitis by targeting USP15 to suppress TNF-α-induced retinal endothelial inflammation.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

A ligandable PNT domain establishes ERG as a directly targetable oncogenic driver in prostate cancer.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Identification of cellular intermediates unveils unique enzymes for flagellar glycan biosynthesis in <i>Clostridioides difficile</i>.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

The structure of correlated variability reflects task-relevant information in sensory neurons.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Shared neurogenetic substrates of nonplanning impulsivity and procrastination.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

HIV-1 capsid interactions with Nuclear Pore Complex components support nuclear entry via affinity gradient.

Proceedings of the National Academy of Sciences of the United States of America·2026
See all related articles

Emerging infectious diseases (EIDs) require new strategies due to increasing global risks. Platform technologies offer faster vaccine and antibody development, but global governance is crucial for coordinated response.

Area of Science:

  • Global Health
  • Epidemiology
  • Biotechnology

Background:

  • Emerging and reemerging infectious diseases (EIDs) pose a persistent global threat, exacerbated by factors like population growth, travel, and climate change.
  • Current approaches to EIDs are technically inadequate and unsustainable.
  • The increasing frequency of EIDs necessitates innovative and coordinated global strategies.

Purpose of the Study:

  • To highlight the limitations of existing strategies for emerging infectious diseases.
  • To explore the potential of platform technologies in accelerating vaccine and therapeutic development.
  • To advocate for a unified global governance framework for EID preparedness and response.

Main Methods:

  • Review of current trends in infectious disease emergence.
Keywords:
EbolaZikaemerging infectious diseaseshuman monoclonalsvaccines

Related Experiment Videos

  • Analysis of the impact of global factors on pathogen evolution and spread.
  • Evaluation of platform technologies for rapid vaccine and monoclonal antibody development.
  • Assessment of existing proposals for EID management.

    • Main Results:

    • Platform technologies enable faster vaccine development and reduced manufacturing costs.
    • New technologies facilitate rapid creation of human monoclonal antibodies for immediate response.
    • Independent proposals for EID management exist but lack unified coordination.
    • A critical need for global governance with strong leadership is identified.

    Conclusions:

    • Platform technologies represent a significant advancement in combating EIDs.
    • Effective management of EIDs requires a coordinated global approach.
    • Establishing a robust global governance structure is essential for international collaboration and response to emerging infectious diseases.